Clinical Air Episode-logo

Clinical Air Episode

United States

More Information

Location:

United States

Language:

English

Contact:

6464390752


Episodes

Nanotechnology Keynote

6/7/2018
More
Nanotechnology Keynote Address given by Omid Farokhzad, MD, Professor, Harvard Medical School and Director, Center for Nanomedicine, Brigham and Women's Hospital Omid Farokhzad is an inventor of more than 145 issued / pending patents. These for the launch of four biotechnology companies: BIND Therapeutics (acquired by Pfizer) Selecta Biosciences, Tarveda Therapeutics (formerly Blend Therapeutics) and Placon Therapeutics (spin-out from Tarveda), which are translating the aforementioned...

Duration:00:32:29

Utilizing a Device Platform Technology across Multiple Therapeutic Categories

6/7/2018
More
Panel: Utilizing a Device Platform Technology across Multiple Therapeutic Categories Most pharma and biotech companies realize the need and benefit of having a platform device technology. The challenge then becomes figuring out how to utilize the device to deliver different types of drugs for various indications such as rheumatoid arthritis, cancer, and rare diseases. Moderator: Paul Jansen Former Associate VP Sanofi and Board Member and Senior Advisor, Haselmeier Panelists: Donna French,...

Duration:00:36:00

CEO Keynote Fireside Chat

6/6/2018
More
The Keynote was bigen by Lars Rebein Sorensen Former President and CEO, Novo Nordisk with Barbara Lueckel, PhD Global Business Development Director Roche Partnering Innovation, Roche

Duration:00:39:48

Addressing R&D Challenges using Drug Delivery Technologies

6/5/2018
More
The expert panel of scientific leaders from industry will discuss current formulation and delivery challenges for therapeutic areas (ophthalmology, immunology, oncology infectious disease, and neurodegenerative area disorders). Each panelist will address a specific disease area and discuss the role of drug delivery in the treatment of disease. The panel will also cover currently available delivery technologies and where improvement is needed. Moderator: Ann Daugherty, PhD Senior Manager,...

Duration:00:44:32

Panel: Hitting the "Reset" Button on Direct-to-CNS Delivery

6/4/2018
More
The expert panel will address the scientific and business challenges and opportunities in this space. Panelists will discuss the difficult nature of providing therapies for diseases of the CNS, covering both device and chemistry-enabled technologies. They will also address questions such as: Can devices take us where chemistry has not?What advances being made in the field of chemis conjugation technologies?Why is intrathecal, intracerebroventricular and intraparenchymal delivery relevant...

Duration:00:49:21

Current and Emerging Drug Delivery Needs in Oncology

6/4/2018
More
Drug Delivery Needs in Oncology Due to the increasing number of parenteral biologic therapies that are administered intravenously, the already high pressure on infusion capacity and healthcare resources is expected further increase. A change from intravenous to subcutaneous dosing has been shown to reduce dosing complexity and overall drug administration related costs. There is keen interest in technologies that facilitate subcutaneous administration and potentially enable drug...

Duration:00:58:01

Building Blocks of IO Clinical Trials - Part 2

5/11/2018
More
Building Blocks of IO Clinical Trials - Part 2 In this episode of Pharma Talk Radio, we continue with Part 2 of the Building Blocks of IO Clinical Trials session led by Andy Lee, SVP and Head of Global Clinical Trial Operations and his team at Merck from the 5th annual IO360° conference. In this final part of the recorded session, we continue to address clinical trial design and operations including: Supply Chain Management and Complexities of Biologics Data Management Project Management...

Duration:00:49:10

Building Blocks of IO Clinical Trials - Part 1

5/10/2018
More
Building Blocks of IO Clinical Trials - Part 1 In this episode of Pharma Talk Radio, we feature Andy Lee, SVP and Head of Global Clinical Trial Operations and his team at Merck who spoke at IO360° in February 2018 on the Building Blocks of IO Clinical Trials. The Merck operations team detailed a day in the life of IO trial functions, how to work collaboratively and effectively, to advance the development of IO therapeutics. This is Part 1 of a 2 Part recording. Part 1 delved into: A...

Duration:01:23:54

Endpoints News Industry Report on IO Collaborations and Trends

5/9/2018
More
Endpoints News Industry Report on IO Collaborations and Trends In this episode of Pharma Talk Radio, John Carroll, Editor-in-Chief of Endpoints News, reviewed the build up of the immuno-oncology space over the past few years at the IO360° conference that took place February 2018. Mr Carroll discussed the impact the large amount of money and the extraordinary numbers that have been invested in the space, have had on collaborations. He also shed light on the natural limitations and...

Duration:00:14:15

CTTI Report - Mobile Clinical Trials Program: Recommendations on Novel Endpoints

4/30/2018
More
Mobile Podcast Series #2 CTTI Findings are in from their Mobile Clinical Trials Program: Recommendations on Novel Endpoints CTTI's Mobile in Clinical Trials program was launched three years ago to propose recommendations that clarify the pathway for developing novel endpoints for use in clinical trials from data generated using mobile technology. Jennifer Goldsack shares recommendations and insights from their findings on: Developing an internal process for identifying endpointsStrategies...

Duration:00:22:18

How a Mobile App Can Offer Unique Value in Assessing Patient Reported Outcomes

4/29/2018
More
Podcast on Mobile in Clinical Trials Series #1 How a Mobile App Can Offer Unique Value in Assessing Patient Reported Outcomes Crescendo Biosciences's CIO, Alex Bangs, reports on how a human-centered design approach was used to create MyRA, an award-winning app for patients living with RA. This podcast comes from the 2017 Mobile in Clinical Trials US event. The next Mobile in Clinical Trials conference is May 15-16 in London and then September 24 in Boston. Mobile is the annual update on...

Duration:00:17:51

Lessons Learned from the Journey of a CMO Leader, Michael Rosenblatt, MD

4/18/2018
More
The Chief Medical Officer Summit is delighted to present a podcast featuring the Keynote Fireside Chat with Michael Rosenblatt, MD, on Lessons Learned from the Journey of a CMO Leader In this session, Dr Rosenblatt, former Merck CMO, will share his insights on career path decision-making and will compare the experiences and lessons learned from being the CMO on the drug development side versus the biotech investor side of the industry. Moderated by CEO of Evelo Biosciences, Simba Gill,...

Duration:00:44:56

Developing a Pathway for Compassionate Use Cases

4/17/2018
More
The Chief Medical Officer Summit is delighted to share a podcast featuring a presentation prepared by Drs Alison Bateman-House and Arthur Caplan of NYU's Division of Medical Ethics on the topic of: Developing a Pathway for Compassionate Use Cases What should the CMO do when they receive a request?What's the role of the CMO, the FDA and the IRB?Lessons learned from Janssen Case StudyHow do you scale down for a biotech?Potential modelsCan the process be accelerated? Join us at the 6th annual...

Duration:00:45:52

2018 Chief Medical Officer Summit Podcast Overview in a Nutshell

4/17/2018
More
This podcasts gives you an overview on what to expect for the 2018 Chief Medical Officer Summit in a nutshell. The concept of the CMO Summit came from MPM Capital’s Dr Elizabeth Stoner, who told us that there is a deep need for a Summit that is designed for CMOs and heads of R&D in the emerging biotech space, specifically, where we can cover all the key issues affecting R&D decisions together with business development issues. The program takes place on May 7th and 8th at the Omni Parker...

Duration:00:06:58

Clinical Research as a Care Option, 2nd annual - 3 min Podcast Overview

3/4/2018
More
In this three minute podcast, you get an overview of one of the hottest topics we are covering in a full day 2nd annual event on Clinical Research as a Care Option. (CRAACO). Making clinical trials a care option is arguably the greatest challenge we can collaborate on in bringing patients closer to clinical trials. CRAACO takes place on April 11th at the Boston Marriott Cambridge. We look at how to integrate clinical research into the overall continuum of patient care and ask, how do we...

Duration:00:03:15

What to Expect at Clinical Trial Collaborations 2018 – 5 min Podcast

3/4/2018
More
This podcast gives you a five minute overview of the 3rd annual Clinical Trial Collaborations conference, otherwise known as CTC. CTC is a strategic level event focused on arguably the most important change in transforming drug development: How and who we collaborate with to drive better clinical trial outcomes? CTC is ideal for people working in clinical trial operations, who are involved with external relationships or need to be involved with external relationships and want to see...

Duration:00:04:54

Mobile in Clinical Trials Europe New for 2018 - 4 min Podcast Overview

3/1/2018
More
The Mobile in Clinical Trials conference comes to Europe for the first time on May 15th and 16th at the Millennium Gloucester Hotel in London. If you work or want to work with mobile and digital technologies to make clinical trials more efficient and reduce patient burden, we highly recommend this conference for you. Using our past four years of experience in the US, we are able to combine the best examples of mobile and digital optimization in clinical trials from the US with examples...

Duration:00:03:54

Patients, a Seat at the Table in Clinical Trials with Pfizer’s Dr Roz Schneider

3/1/2018
More
Dr Roslyn Schneider, Global Patient Affairs Lead at Pfizer, speaks with Valerie Bowling, Executive Director, Patients as Partners, in a podcast interview on patients at the center of clinical research. Dr Schneider, better known as Roz, helps drive patient centricity and the integration of the patiemt voice throughout the development of medicines at Pfizer. She gives us a brief history of the evolution of the involvement of patients in clinical research, next steps, and how patients and...

Duration:00:16:25

Reducing the Burden of Type 1 Diabetes with Patient Dana Lewis:DPharm Podcast #5

2/19/2018
More
DPharm Podcast Series #5 Reducing the Burden of Type 1 Diabetes through a Model of Democratized R&D Patient advocate star, Dana Lewis, founder of OpenAPS delivers a powerful session at DPharm on an idea to reduce the burden of type 1 diabetes with a smart system she created through open soucre. Learn how she drive the idea and creation of the "Self driving car for diabetes". The next DPharm conference is September 25-26 in Boston. DPharm reports on innovation and disruptive innovation to...

Duration:00:27:44

5th Annual Patients as Partners What to Expect Overview Podcast in 7 Minutes

2/19/2018
More
5th Annual Patients as Partners What to Expect Overview Podcast Officially approved by Patients Included, Patients as Partners is the only program in the US that truly demonstrates how to involve patients throughout the entire medicines development life cycle to drive greater efficiencies in clinical research. Taking place March 15-16 in Philadelphia, the focus of this year’s program is on turning discussion into action, and Kate Woda, the Conference Director has worked meticulously with...

Duration:00:07:04